Tenders/Pharmaceutical products (Miscellaneous pharmaceutical products)
Awarded🇺🇦UkraineSuppliesThis tender has expired

Pharmaceutical products (Miscellaneous pharmaceutical products)

Auto-translated from uk
Original title: Фармацевтична продукція (Фармацевтична продукція різна)
Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня"
Published: Apr 9, 2026
Updated: Aug 4, 2026
Source: ProZorro Ukraine

About This Opportunity

Translated

Procurement of various pharmaceutical products, including Allopurinol tablets. The origin must not be from the Russian Federation, Republic of Belarus, or Islamic Republic of Iran.

This is a supplies contract in the general supplies sector, with a focus on Printing. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 858,720.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from uk

By submitting their price proposal, the participant confirms that the proposed goods do not originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran.

Items: Allopurinol tablets 300 mg (Medicinal products for the treatment of dermatological diseases and musculoskeletal disorders) [CPV: 33630000-5]; Ammonia solution for external use, 10%, 100 ml per bottle (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Amitriptyline tablets 25 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Atorvastatin tablets 20 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Atorvastatin tablets 40 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Atorvastatin tablets 80 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Acetazolamide tablets 250 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Benzyl benzoate emulsion for skin, 200 mg/g, 50 g per vial (Miscellaneous medicinal products) [CPV: 33690000-3]; Dabigatran etexilate hard capsules 150 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Desmopressin nasal spray, 0.1 mg/ml, 5 ml per bottle (Medicinal products for the treatment of genitourinary system diseases and hormones) [CPV: 33640000-8]; Enalapril tablets 10 mg /12.5 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Epoetin alfa, solution for injection, 2000 IU, 1 ml per syringe (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Epoetin alfa, solution for injection, 4000 IU, 1 ml per syringe (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Ibuprofen tablets/capsules 400 mg (Medicinal products for the treatment of dermatological diseases and musculoskeletal disorders) [CPV: 33630000-5]; Isosorbide spray, 1.25 mg/dose, 15 ml per bottle (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Isosorbide concentrate/solution, 1 mg/ml, 10 ml per vial (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Human insulin (Combination: 30% Short-acting; 70% Intermediate-acting), suspension for injection, 100 IU/ml, cartridge, 3 ml per cartridge (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Human insulin (Intermediate-acting), suspension for injection, 100 IU/ml, cartridge, 3 ml per cartridge (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Quetiapine, film-coated tablets, 100 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Lamotrigine tablets 100 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Lamotrigine tablets 25 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Lithium capsules 300 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Metronidazole tablets/capsules 250 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Moxifloxacin film-coated tablets 400 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Sodium thiosulfate solution for injection 300mg/ml 5ml (Miscellaneous medicinal products) [CPV: 33690000-3]; Nitroglycerin sublingual tablets 0.5 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Nifedipine tablets 10 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Paracetamol oral suspension/syrup 120 mg/5ml 100 ml (Medicinal products for the treatment of dermatological diseases and musculoskeletal disorders) [CPV: 33630000-5]; Senna tablets, 70 mg (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Oral rehydration salts, powder for oral solution, 18.9 g per sachet (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Timolol eye drops, 5 mg/ml, 10 ml per bottle (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Pancreatin, Lipolytic units: 8000 (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Furosemide tablets 40 mg (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Cyclopentolate eye drops, 1%, 5 ml per bottle (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Ciprofloxacin film-coated tablets 500 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Mupirocin nasal ointment, 2%, 3 g per tube (Medicinal prod...

Data provenance

This notice is sourced from ProZorro Ukraine and was originally published on April 9, 2026. Last refreshed 106 days ago. Original language: uk. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня"

Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня" has issued 101 procurement notices on BidsFactory, including 2 currently open and 31 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Agriculture & Food Security. All notices are published for Ukraine. Notices are distributed via ProZorro Ukraine. Most recent publication: November 18, 2026.

Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня": buyer profile, tenders and awards

Frequently asked questions about this tender

How much was the contract awarded for?

ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ «ФАРМІННОВАЦІЇ» was awarded the contract for UAH 854,020. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Ukraine. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit ProZorro Ukraine to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to ТОВАРИСТВО З ОБМЕЖЕНОЮ ВІДПОВІДАЛЬНІСТЮ «ФАРМІННОВАЦІЇ». The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня" in Ukraine. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Key Details

Submission Deadline
Apr 3, 2026
Deadline passed
Estimated Budget
UAH 858,720
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
uk

Source

prozorro_ua
ProZorro Ukraine
Public Procurement

Contracting Authority

Комунальне некомерційне підприємство "Нововолинська центральна міська лікарня"
🇺🇦Ukraine